Analysis of patients with smear positive pulmonary tuberculosis using second line anti-tuberculosis drugs and its affecting factors in Huian county

CHEN Jiang-fen, LIN Shu-fang, DU Yong-cheng, CHEN Dai-quan, ZHOU Yin-fa

Anhui Journal of Preventive Medicine ›› 2016, Vol. 22 ›› Issue (4) : 237-239.

PDF(756 KB)
PDF(756 KB)
Anhui Journal of Preventive Medicine ›› 2016, Vol. 22 ›› Issue (4) : 237-239.

Analysis of patients with smear positive pulmonary tuberculosis using second line anti-tuberculosis drugs and its affecting factors in Huian county

  • CHEN Jiang-fen, LIN Shu-fang, DU Yong-cheng, CHEN Dai-quan, ZHOU Yin-fa
Author information +
History +

Abstract

Objective To understand the information about using second line anti-tuberculosis drugs in smear positive pulmonary tuberculosis cases in Huian county, and provide evidence for policies about using SLD. Methods Using the united questionnaire to retrospectively investigate the smear positive pulmonary tuberculosis cases in Huian county from 2010 to 2012. We analyzed the cases data, information of SLD use and affecting factors. Results A total of 741 patients were new cases and 116 were retreated cases. The successful treatment rate of pulmonary tuberculosis cases using SLD was 79.88%, and that of cases without SLD was 87.15%, which showed statistical significance between the two rates. The factors affecting the use of SLD were pulmonary cavity in X ray, therapeutic classification, lesions locus in lung field and sex(P<0.05). Conclusion The smear positive TB cases should be treated with the standard regimen before the DST or waiting the results, in order to avoid irregularly use of SLD.

Key words

Pulmonary tuberculosis / Smear positive / SLD

Cite this article

Download Citations
CHEN Jiang-fen, LIN Shu-fang, DU Yong-cheng, CHEN Dai-quan, ZHOU Yin-fa. Analysis of patients with smear positive pulmonary tuberculosis using second line anti-tuberculosis drugs and its affecting factors in Huian county[J]. Anhui Journal of Preventive Medicine. 2016, 22(4): 237-239

References

[1] 蔡纪明, 陈贤义.中国结核病控制工作典范--世界银行贷款传染病与地方病控制项目结核病控制部分终期评价报告[M].北京:人民卫生出版社, 2003 .17-21.
[2] 屠德华.肺结核化学治疗中标准化方案与个体化方案的应用[J].中华结核和呼吸杂志, 2004 ,27 (2):75-76.
[3] 陈伟,王雪静,王黎霞,等. 全国五省结核病与性别关系的研究[J].中国防痨杂志,2010,32(9):534-539.
[4] 胡远莲, 何广学, 刘志敏,等. 我国SLD使用现状调查研究[J].中国防痨杂志, 2010, 32(11): 706- 709.
[5] 李文婧,孙强,闫赟,等. 结核病专科医院和结防机构SLD使用现状调查[J]. 中国防痨杂志, 2010, 32(3): 123- 128.
[6] Ben Amor Y, Day MS, Schluger NW. Preventing the next generation of extensively drug-resistant tuberculosis[J]. Int J Tuberc Lung Dis, 2010 ,14(5):525-527.
[7] Shah NS, Pratt R, Armstrong L. et al. Extensively drug-resistant tuberculosis in the United States, 1993-2007[J]. JAMA, 2008, 300(18):2153-2160.
PDF(756 KB)

Accesses

Citation

Detail

Sections
Recommended

/